Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-01

Clinical Trial Update: Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the efficacy and safety of Sipjeondaebo-tang for cold hypersensitivity in the hands and feet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sipjeondaebo-tang

Snippet

Sponsor: Gachon University Gil Oriental Medical Hospital | Conditions: Cold Hypersensitivity | Phase 2, Phase 3 | Status: COMPLETED